2023-2024 Pan-Canadian Pharmaceutical Alliance impact report
By EsqSocial Corporation 23/12/24
On November 22, 2024, the pan-Canadian Pharmaceutical Alliance (pCPA) released its 2023-2024 impact report. According to the pCPA, estimated dollar savings for public drug plans from pCPA negotiations were $4.63 billion ($3.72 billion on brand-name drugs and $0.91 billion on generic drugs), an increase from the estimated $3.89 billion in 2022-2023....
By: Smart & Biggar